Molecular predictors of response to tyrosine kinase inhibitors in patients with Non-Small-Cell Lung Cancer

被引：0
|
作者：
Samuel Murray
Vasilios Karavasilis
Mattheos Bobos
Evangelia Razis
Savvas Papadopoulos
Christos Christodoulou
Paris Kosmidis
George Fountzilas
机构：
[1] BioMarker Solutions Ltd,Department of Molecular Oncology
[2] GeneKOR,Department of Medical Oncology
[3] “Papageorgiou” Hospital,Department of Pathology
[4] Aristotle University of Thessaloniki School of Medicine,First Department of Medical Oncology
[5] Aristotle University of Thessaloniki School of Medicine,Department of Pathology
[6] “Hygeia” Hospital,Second Department of Medical Oncology
[7] “Hygeia” Hospital,Second Department of Medical Oncology
[8] “Metropolitan” Hospital,undefined
[9] “Hygeia” Hospital,undefined
来源：
Journal of Experimental & Clinical Cancer Research | / 31卷
关键词：
Predictive; Somatic mutation; EGFR; Gefitinib; Erlotinib; Response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Molecular predictors of response to tyrosine kinase inhibitors in patients with Non-Small-Cell Lung Cancer
    Murray, Samuel
    Karavasilis, Vasilios
    Bobos, Mattheos
    Razis, Evangelia
    Papadopoulos, Savvas
    Christodoulou, Christos
    Kosmidis, Paris
    Fountzilas, George
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2012, 31
  • [2] Clinical and molecular predictors of response to EGFR tyrosine kinase inhibitors in non-small cell lung cancer
    Rouge, Thibault de La Motte
    Valent, Alexander
    Ambrosetti, Damien
    Vielh, Philippe
    Lacroix, Ludovic
    ANNALES DE PATHOLOGIE, 2007, 27 (05) : 353 - 363
  • [3] Tyrosine kinase inhibitors for non-small-cell lung cancer: finding patients who will be responsive
    Santarpia, Mariacarmela
    Altavilla, Giuseppe
    Salazar, Maria F.
    Magri, Ignacio
    Pettineo, Giuseppe
    Benecchi, Sara
    Rosell, Rafael
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2011, 5 (03) : 413 - 424
  • [4] Relevance of genotyping non-small-cell lung cancer patients on response to platinum-basedchemotherapy and tyrosine kinase inhibitors
    Campos-Parra, Alma D.
    Cruz, Graciela
    Zuloaga, Carlos
    Aviles, Alejandro
    Manriquez, Maria E. Vazquez
    Borbolla-Escoboza, Jose R.
    Cardona, Andres
    Abelardo, Meneses
    Arrieta, Oscar
    CLINICAL CANCER RESEARCH, 2012, 18 (03)
  • [5] Molecular predictors of chemotherapy response in non-small-cell lung cancer
    Gray, Jhanelle
    Simon, George
    Bepler, Gerold
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (04) : 545 - 549
  • [6] Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer
    Yao, Yu
    Yang, Huaping
    Zhu, Bo
    Wang, Song
    Pang, Jiaohui
    Wu, Xiaoying
    Xu, Yang
    Zhang, Junli
    Zhang, Jinfeng
    Ou, Qiuxiang
    Tian, Hui
    Zhao, Zheng
    RESPIRATORY RESEARCH, 2023, 24 (01)
  • [7] Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer
    Yu Yao
    Huaping Yang
    Bo Zhu
    Song Wang
    Jiaohui Pang
    Xiaoying Wu
    Yang Xu
    Junli Zhang
    Jinfeng Zhang
    Qiuxiang Ou
    Hui Tian
    Zheng Zhao
    Respiratory Research, 24
  • [8] Second-generation tyrosine kinase inhibitors in non-small-cell lung cancer
    Herbst, Roy S.
    CLINICAL LUNG CANCER, 2007, 8 : S50 - S51
  • [9] Strategies to overcome resistance to tyrosine kinase inhibitors in non-small-cell lung cancer
    Santarpia, Mariacarmela
    Gil, Nuno
    Rosell, Rafael
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2015, 8 (04) : 461 - 477
  • [10] Predictive signature of response to EGFR tyrosine kinase inhibitors in non-small-cell lung cancer cells by tyrosine kinase activity profiling
    Izawa, Naoki
    Serizawa, Masakuni
    Naji, Faris
    de Wijn, Rik
    Hilhorst, Riet
    Ruijtenbeek, Rob
    Yasui, Hirofumi
    Nakajima, Takako
    Boku, Narikazu
    Koh, Yasuhiro
    CANCER RESEARCH, 2014, 74 (19)
12345